Huining Kang

3.9k total citations · 1 hit paper
60 papers, 1.4k citations indexed

About

Huining Kang is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Huining Kang has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Oncology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Huining Kang's work include Acute Lymphoblastic Leukemia research (11 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Huining Kang is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Huining Kang collaborates with scholars based in United States, China and Denmark. Huining Kang's co-authors include Scott A. Ness, Kathryn J. Brayer, Stephen P. Hunger, William L. Carroll, Cheryl L. Willman, Richard C. Harvey, Charles G. Mullighan, Meenakshi Devidas, Andrew J. Carroll and W. Paul Bowman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bioinformatics.

In The Last Decade

Huining Kang

60 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microplastic presence in dog and human testis and its potential association with sperm count and weights of testis and epididymis

2024 107 citations Marcus A. Garcia, Alexander Nihart et al. Toxicological Sciences profile →

Peers

Countries citing papers authored by Huining Kang

Since Specialization

Citations

This map shows the geographic impact of Huining Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huining Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huining Kang more than expected).

Fields of papers citing papers by Huining Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huining Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huining Kang. The network helps show where Huining Kang may publish in the future.

Co-authorship network of co-authors of Huining Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Huining Kang. A scholar is included among the top collaborators of Huining Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huining Kang. Huining Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Microplastic presence in dog and human testis and its potential association with sperm count and weights of testis and epididymis breakdown → 2024 ·Toxicological Sciences ·(unknown), Marcus A. Garcia, Alexander Nihart, Rui Liu, Lei Yin, Natalie L. Adolphi, Daniel F. Gallego, Huining Kang, Matthew J. Campen, Xiaozhong Yu	107
2	Early menopause and hormone therapy as determinants for lung health outcomes: a secondary analysis using the PLCO trial 2024 ·Thorax ·(unknown), Yue Feng, (unknown), Huining Kang, (unknown), Kimberly K. Leslie, Yiliang Zhu, Jennifer A. Doherty, Yan Guo, Steven A. Belinsky, Linda Cook, Shuguang Leng	2
3	The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis 2023 ·Antiviral Research ·(unknown), (unknown), Rosa T. Sterk, (unknown), (unknown), Donna F. Kusewitt, Huining Kang, Michelle A. Ozbun	2
4	Multimodel habitats constructed by perfusion and/or diffusion MRI predict isocitrate dehydrogenase mutation status and prognosis in high-grade gliomas 2023 ·Clinical Radiology ·Jian Liu, Chunxiao Cong, Jing Zhang, Jie Qiao, Hong Guo, Hao Wu, (unknown), Huining Kang, Jian Fang, Wei Zhang	6
5	Self-Selected Walking Cadence after 16-Week Light-Intensity Physical Activity Intervention for Older Cancer Survivors 2022 ·International Journal of Environmental Research and Public Health ·Elizabeth Harding, Ann L. Gibson, Huining Kang, Micah Zuhl, (unknown), Cindy K. Blair	4
6	Wood smoke exposure affects lung aging, quality of life, and all-cause mortality in New Mexican smokers 2022 ·Respiratory Research ·Shuguang Leng, Maria A. Picchi, Paula Meek, Menghui Jiang, (unknown), (unknown), (unknown), Yohannes Tesfaigzi, Matthew J. Campen, Huining Kang, Yiliang Zhu, Qing Lan, Akshay Sood, Steven A. Belinsky	7
7	Transcriptomic changes due to early, chronic intermittent alcohol exposure during forebrain development implicate WNT signaling, cell‐type specification, and cortical regionalization as primary determinants of fetal alcohol syndrome 2021 ·Alcoholism Clinical and Experimental Research ·(unknown), Praveen Chander, Huining Kang, Nikolaos Mellios, Jason P. Weick	8
8	A Home-Based Mobile Health Intervention to Replace Sedentary Time With Light Physical Activity in Older Cancer Survivors: Randomized Controlled Pilot Trial 2021 ·JMIR Cancer ·Cindy K. Blair, Elizabeth Harding, Charles L. Wiggins, Huining Kang, Matthew Schwartz, (unknown), (unknown), Anita Y. Kinney	35
9	Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA 2019 ·RNA Biology ·Bo Ye, Jianxin Shi, Huining Kang, (unknown), Deirdre A. Hill, Hui Yu, Scott A. Ness, Fei Ye, Jie Ping, (unknown), Jeremy S. Edwards, Ying‐Yong Zhao, Yan Guo	20
10	Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL 2018 ·Biomarker Research ·Huining Kang, Nitesh Sharma, Christian K. Nickl, Meenakshi Devidas, Mignon L. Loh, Stephen P. Hunger, Kimberly P. Dunsmore, Stuart S. Winter, Ksenia Matlawska‐Wasowska	9
11	Dietary Nutrient Intake, Ethnicity, and Epigenetic Silencing of Lung Cancer Genes Detected in Sputum in New Mexican Smokers 2017 ·Cancer Prevention Research ·Shuguang Leng, Maria A. Picchi, Huining Kang, Guodong Wu, Piotr T. Filipczak, Daniel E. Juri, (unknown), W. James Gauderman, Frank D. Gilliland, Steven A. Belinsky	10
12	SOCS5 Regulates JAK-STAT Signaling and T-ALL Development 2017 ·Blood ·Nitesh Sharma, Christian K. Nickl, Huining Kang, Stuart S. Winter, Judy L. Cannon, Ksenia Matlawska‐Wasowska	1
13	Default Patterning Produces Pan-cortical Glutamatergic and CGE/LGE-like GABAergic Neurons from Human Pluripotent Stem Cells 2017 ·Stem Cell Reports ·Crina M. Floruta, Ruofei Du, Huining Kang, Jason L. Stein, Jason P. Weick	15
14	Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor–Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma 2015 ·Cancer Discovery ·Kathryn J. Brayer, (unknown), Huining Kang, Scott A. Ness	167
15	A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients 2015 ·Clinical Cancer Research ·Yuna Guo, S. Ray Kenney, Linda S. Cook, Sarah F. Adams, Teresa Rutledge, Elsa Romero, Tudor I. Oprea, Larry A. Sklar, Edward J. Bedrick, Charles L. Wiggins, Huining Kang, Lesley Lomo, Carolyn Y. Muller, Angela Wandinger‐Ness, Laurie G. Hudson	39
16	High Incidence of ErbB3, ErbB4, and MET Expression in Ovarian Cancer 2014 ·International Journal of Gynecological Pathology ·(unknown), (unknown), Lesley Lomo, Mara P. Steinkamp, Huining Kang, Carolyn Y. Muller, Bridget S. Wilson	44
17	Scoring of MYC protein expression in diffuse large B-cell lymphomas: concordance rate among hematopathologists 2014 ·Modern Pathology ·(unknown), Tracy I. George, David R. Czuchlewski, Qianyun Zhang, Carla S. Wilson, Cordelia E. Sever, (unknown), Dahua Zhang, (unknown), Kaaren K. Reichard, Huining Kang, Kathryn Foucar, Mohammad A. Vasef	26
18	CD34+ megakaryocytes (≥30%) are associated with megaloblastic anaemia and non‐acute myeloid neoplasia 2012 ·Histopathology ·(unknown), (unknown), Huining Kang, Kaaren K. Reichard	7
19	Pediatric B-lymphoblastic leukemia with RUNX1 amplification: clinicopathologic study of eight cases 2011 ·Modern Pathology ·Kaaren K. Reichard, Huining Kang, (unknown)	13
20	Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia 2010 ·Blood ·Richard C. Harvey, Charles G. Mullighan, I‐Ming Chen, Walker Wharton, Fady M. Mikhail, Andrew J. Carroll, Huining Kang, Wei Liu, Kevin K. Dobbin, Malcolm A. Smith, William L. Carroll, Meenakshi Devidas, W. Paul Bowman, Bruce M. Camitta, Gregory H. Reaman, Stephen P. Hunger, James R. Downing, Cheryl L. Willman	395

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact